hydroxychloroquine has been researched along with ST Elevation Myocardial Infarction in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
ST Elevation Myocardial Infarction: A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Pelle, MC | 1 |
Tassone, B | 1 |
Ricchio, M | 1 |
Mazzitelli, M | 1 |
Davoli, C | 1 |
Procopio, G | 1 |
Cancelliere, A | 1 |
La Gamba, V | 1 |
Lio, E | 1 |
Matera, G | 1 |
Quirino, A | 1 |
Barreca, GS | 1 |
Trecarichi, EM | 1 |
Torti, C | 1 |
1 other study available for hydroxychloroquine and ST Elevation Myocardial Infarction
Article | Year |
---|---|
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.
Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Asymptomatic Infections; Az | 2020 |